NDC 80425-0041-01 - Meloxicam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0041
- Requested NDC
- 80425-0041-01
- Package NDCs from labels
- 80425-0041-3, 80425-0041-2, 80425-0041-1, 80425-0041-4, 80425-0041-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2026-03-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Meloxicam - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2026-03-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0041-1 | Meloxicam | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 80425-0041-2 | Meloxicam | 60 in 1 BOTTLE | TABLET | 60 | 9 | |
| 80425-0041-3 | Meloxicam | 90 in 1 BOTTLE | TABLET | 90 | 9 | |
| 80425-0041-4 | Meloxicam | 6 in 1 BOTTLE | TABLET | 6 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0041 | MELOXICAM TABLET [ADVANCED RX OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 4 package rows | 20250101_af9ce58c-3cd7-769f-e053-2a95a90a5385.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0041-1 | EA - Each | 80425-0041 | 976a2e18-f918-450a-a711-aaa83b01ac48 | 1 | 2023-04-07 |
| 80425-0041-2 | EA - Each | 80425-0041 | 7421f63a-621e-4bd7-ae5c-0734afdc147a | 1 | 2023-04-07 |
| 80425-0041-3 | EA - Each | 80425-0041 | 07712d30-38f4-42fe-a5ac-05b9301c1914 | 1 | 2023-04-07 |
| 80425-0041-4 | EA - Each | 80425-0041 | 27bedd73-2fc0-4f21-a033-6c378c798c50 | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meloxicam | MELOXICAM | American Health Packaging | 937ea2ca-6b8c-4c80-9926-f4de7c8f5643 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Lupin Pharmaceuticals, Inc. | 43e2b0f3-cf34-4f51-aa93-39ed98cab449 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | AvPAK | ee8df8fa-d08a-8c8b-f048-813e5022a101 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
| meloxicam | MELOXICAM | PHOENIX RX LLC | 3ede6724-d9be-5b44-e063-6294a90afbaa | 2025-09-15 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| MELOXICAM | MELOXICAM | Cipla USA Inc. | bb83cd61-0a82-4fe0-b72e-5b715cbd656d | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
| MELOXICAM | MELOXICAM | PHOENIX RX LLC | 3b1938e5-7a9e-b214-e063-6394a90a1270 | 2025-08-13 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| XIFYRM | MELOXICAM | Azurity Pharmaceuticals, Inc. | bf2b198c-0726-488a-b911-4fe394e4b56e | 2025-06-18 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | ANI Pharmaceuticals, Inc. | ce9a8fd7-9bd2-4793-82f3-0fb8f0965d0f | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Asclemed USA, Inc. | 6d7ede5a-c12e-4979-a47a-f3346ea5bc80 | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Carlsbad Technology, Inc. | 20871c7f-1e36-49ef-8e2b-70112430ca1e | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | d3182622-4b9b-4850-bf9f-108c5610eb40 | 2025-04-01 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 75af3e09-f510-45a4-9f21-50bff7aa5510 | 2025-03-21 | Boxed warning, Warnings, Adverse reactions | 311486 VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 218e71c6-265a-45f4-b660-5c1da5a36bd2 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Aurobindo Pharma Limited | d5e12448-1ca1-46a4-8de4-e8b94567e5a8 | 2025-03-15 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
| MELOXICAM | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 2eaac8b2-d50a-a0bc-e063-6294a90a7cac | 2025-02-21 | Boxed warning, Warnings, Adverse reactions | 311486 VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | 29974b41-68b4-42cf-8835-18ae480c2952 | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | 311486 VG2QF83CGL |
| meloxicam | MELOXICAM | Asclemed USA, Inc. | 4dc34489-cbb6-4e57-a2cc-a274209456f3 | 2025-02-06 | Boxed warning, Warnings, Adverse reactions | ANDA077927 152695 VG2QF83CGL |
| MELOXICAM | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 25b742d8-5a95-9ec8-e063-6294a90a89ae | 2025-01-03 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
| meloxicam | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 4acea0aa-973f-40e5-88b4-0e2d85ea624c | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | ANDA077927 311486 VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.